CYP1A2 polymorphism may contribute to agomelatine-induced acute liver injury: Case report and review of the literature

RATIONALE: Liver function monitoring is recommended when agomelatine is prescribed, although liver enzymes are not considered predictive biomarkers. Most patients present with acute liver injury, with only a few presenting with levels of liver enzymes that are over 30 times the upper limit of normal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shushan, Xu, Qing, Qu, Kankan, Wang, Jun, Zhou, Zhenhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545369/
https://www.ncbi.nlm.nih.gov/pubmed/34766583
http://dx.doi.org/10.1097/MD.0000000000027736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545369/
https://www.ncbi.nlm.nih.gov/pubmed/34766583
http://dx.doi.org/10.1097/MD.0000000000027736

Ejemplares similares